Education
About Us
Working with TipRanks
Follow Us
Ani Pharmaceuticals (ANIP)
:ANIP
ANI Pharmaceuticals (ANIP) Ownership Overview
11.10% Insiders
20.25% Mutual Funds
23.46% Other Institutional Investors
18.68% ETFs
26.51% Public Companies and
Individual Investors
The ownership structure of ANI Pharmaceuticals (ANIP) stock is a mix of institutional, retail, and individual investors. Approximately 62.39% of the company’s stock is owned by Institutional Investors, 11.10% is owned by Insiders, and 26.51% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 07, 2025 | Ori Gutwerg Svp, Generics | xxxxxxxxxxxxx | $323049 |
| Dec 18, 2024 | Stephen P. Carey Svp & Cfo | xxxxxxxxxxxxx | $418425 |
| Nov 27, 2024 | Nikhil Lalwani President & Ceo,director | xxxxxxxxxxxxx | $1941442 |
| Nov 18, 2024 | Christopher Mutz Head Of Rare Disease | xxxxxxxxxxxxx | $375050 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $328750 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $351470 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $1741320 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $3160910 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,007,898 | Institution | 9.23% | 125,473,546 | |
| 1,066,279 | Institution | 4.90% | 66,631,775 | |
| 833,286 | Institution | 3.83% | 52,072,042 | |
| 730,208 | Insider | 3.36% | 45,630,698 | |
| 722,003 | Institution | 3.32% | 45,117,967 | |
| 485,634 | Insider | 2.23% | 30,347,269 | |
| 350,745 | Institution | 1.61% | 21,918,055 | |
| 331,558 | Institution | 1.52% | 20,719,059 | |
| 327,887 | Institution | 1.51% | 20,489,659 | |
| 324,557 | Institution | 1.49% | 20,281,567 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 833,286 | Institution | 3.83% | 52,072,042 | |
| 722,003 | Institution | 3.32% | 45,117,967 | |
| 350,745 | Institution | 1.61% | 21,918,055 | |
| 327,887 | Institution | 1.51% | 20,489,659 | |
| 324,557 | Institution | 1.49% | 20,281,567 | |
| 204,465 | Institution | 0.94% | 12,777,018 | |
| 187,721 | Institution | 0.86% | 11,730,685 | |
| 168,324 | Institution | 0.77% | 10,518,567 | |
| 158,287 | Institution | 0.73% | 9,891,355 | |
| 122,686 | Institution | 0.56% | 7,666,648 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,047,517 | Institution | 4.81% | 65,459,337 | |
| 579,994 | Institution | 2.67% | 34,010,848 | |
| 497,279 | Institution | 2.29% | 31,074,965 | |
| 253,428 | Institution | 1.16% | 14,861,018 | |
| 151,534 | Institution | 0.70% | 9,469,360 | |
| 147,900 | Institution | 0.68% | 9,089,195 | |
| 132,537 | Institution | 0.61% | 8,282,237 | |
| 115,285 | Institution | 0.53% | 7,204,160 | |
| 87,144 | Institution | 0.40% | 5,355,435 | |
| 82,336 | Institution | 0.38% | 4,828,183 |
FAQ
Who Owns Ani Pharmaceuticals (ANIP)?
According to the latest TipRanks data, approximately 23.46% of the company's stock is held by institutional investors, 11.10% is held by insiders, and 26.51% is held by retail investors.
What percentage of Ani Pharmaceuticals (ANIP) stock is held by institutional investors?
According to the latest TipRanks data, approximately 23.46% of Ani Pharmaceuticals (ANIP) stock is held by institutional investors.
What percentage of Ani Pharmaceuticals (ANIP) stock is held by retail investors?
According to the latest TipRanks data, approximately 26.51% of Ani Pharmaceuticals (ANIP) stock is held by retail investors.
Who owns the most shares of Ani Pharmaceuticals (ANIP)?
iShares owns the most shares of Ani Pharmaceuticals (ANIP).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.